2012-09-27 18:29:25 - New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research

This analysis examines the historical and forecast performance for Bristol-Myers Squibb in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Scope
* Gain insight into Bristol-Myers Squibb's strategic outlook across the next 6 years
* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

Highlights

Strategic insight into the prospects for BMS over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.


Full Report Details at
-

www.fastmr.com/prod/464833_bristolmyers_squibb_co_company_analys ..


Reasons to Get this Report
* Benchmark BMS's performance against key rivals in the prescription pharmaceutical sector
* Determine the value of BMS's piepline and other strategies the company is taking to counteract an imminent wave of generic compeitition

Report Table of Contents:

SCOPE OF ANALYSIS

* PharmaVitae Explorer database
* Analysis structure

* Executive summary
* Strategic insight
* Company overview
* Operating performance analysis

EXECUTIVE SUMMARY

* Key findings
* Bristol-Myers Squibb prescription pharmaceutical sales outlook
* Bristol-Myers Squibb financial outlook
* SWOT analysis

* Strengths
* Weaknesses
* Opportunities
* Threats

STRATEGIC INSIGHT

* Launch/core/expiry analysis
* Therapy area focus shift set to take place as mature disease portfolios succumb to expiry
* Productivity transformation initiative implemented to lower operating costs by $2.5bn

COMPANY OVERVIEW

* Key findings
* Background
* M&A history

* M&A strategy

OPERATING PERFORMANCE ANALYSIS

* Key findings
* Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2005-11
* Operating costs and profit analysis

* Operating costs and profit analysis, 2005-17
* Operating cost ratio and profit margin analysis, 2005-17

APPENDIX

* Exchange rates

TABLES

* Table: Datamonitor's established pharmaceutical company coverage, 2012
* Table: Bristol-Myers Squibb - key product overview ($m), 2011-17
* Table: Bristol-Myers Squibb's financial performance ($m), 2011-17
* Table: Bristol-Myers Squibb launch, core and expiry portfolio overview ($m), 2011-17
* Table: Bristol-Myers Squibb's key therapeutic franchise sales ($m), 2011 and 2017
* Table: Bristol-Myers Squibb key merger and acquisition deals, 200-12
* Table: Total Bristol-Myers Squibb sales by business unit ($m), 2005-11
* Table: Bristol-Myers Squibb operating revenue/cost analysis ($m), 2005-11
* Table: Bristol-Myers Squibb operating revenue/cost analysis ($m), 2011-17
* Table: Bristol-Myers Squibb operating cost ratio analysis (percentage of total revenues), 2005-11
* Table: Bristol-Myers Squibb operating cost ratio analysis (percentage of total revenues), 2011-17
* Table: Exchange rates, 2012

FIGURES

* Figure: The PharmaVitae Explorer
* Figure: Bristol-Myers Squibb's prescription pharmaceutical performance, sales ($m) and growth rate 2005-17
* Figure: Bristol-Myers Squibb's financial performance ($m), 2005-17
* Figure: Bristol-Myers Squibb launch/core/expiry configuration ($m), 2011-17
* Figure: Bristol-Myers Squibb total sales, by therapy area 2005-17
* Figure: Sales compound annual growth rates across the total prescription pharma market, by therapy area 2011-17
* Figure: Bristol-Myers Squibb operating revenue/cost analysis ($m), 2005-17

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at www.fastmr.com/catalog/publishers.aspx?pubid=1002

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.